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Background: There has been recent evidence suggesting the presence of anti-thyroid peroxidase antibodies
(TPOAb) increases the risk of miscarriage, and levothyroxine can rescue miscarriages associated with TPOAb. We
propose the most clinically pragmatic cohort to screen for TPOAb are women presenting for management of a
missed miscarriage and have never birthed a liveborn. We measured serum TPOAb among nulliparous women
presenting for management of miscarriage, and compared levels with women who have had 2 or more livebirths
(and never miscarried). Given its potential role in immunomodulation, we also measured Vitamin D levels.
Methods: We performed a prospective descriptive cohort study at a tertiary hospital (Mercy Hospital for Women,
Victoria, Australia). We measured TPOAb and Vitamin D levels in serum obtained from 118 nulliparous women
presenting for management of miscarriage, and 162 controls with 2 or more livebirths (and no miscarriages).
Controls were selected from a serum biobank prospectively collected in the first trimester at the same hospital.
Results: Nulliparous women with 1 or more miscarriages had higher thyroid peroxidase antibody (TPOAb) levels
than those with 2 or more livebirths; TPOAb in miscarriage group was 0.3 mIU/L (interquartile range [IR]: 0.2-0.7)
vs 0.2 mIU/L among controls (IR 0.0-0.5; p < 0.0001). We confirmed TPOAb levels were not correlated with serum
human chorionic gonadotrophin (hCG) concentrations in either the miscarriage or control groups. In contrast,
thyroid stimulating hormone, fT3 and fT4 levels (thyroid hormones) either trended towards a correlation, or were
significantly correlated with serum hCG levels in the two groups. Of the entire cohort that was predominantly
caucasian, only 12% were Vitamin D sufficient. Low Vitamin D levels were not associated with miscarriage.
Conclusions: We have confirmed the association between miscarriage and increased TPOAb levels. Furthermore, it
appears TPOAb levels in maternal blood are not influenced by serum hCG levels. Therefore, we propose the day
nulliparous women present for management for miscarriage is a clinically relevant, and pragmatic time to screen
for TPOAb.
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Miscarriage is the most common complication of preg-
nancy. Despite this, there are no established treatments
that can prevent most cases of sporadic miscarriages.
Therefore, any potential therapeutic leads would be of
avid interest to clinicians.
An association between circulating thyroid peroxidase
antibodies (TPOAb) and miscarriage has been found by
a number of observational studies and confirmed by a
recent meta-analysis [1] (Thyroid peroxidase is an en-
zyme that helps produce the thyroid hormones T3 and
T4, by liberating iodine so it can be added to tyrosine
residues on thyroglobulin). Proposed hypotheses’ to ac-
count for this association include direct pathogenicity of
thyroid autoantibodies, that the presence of thyroid
autoantibodies is a marker for generalized autoimmun-
ity, or thyroid autoantibodies may directly diminish thy-
roid reserve and increase the risk of miscarriage [2-4].
Of particular clinical relevance, there is evidence trea-
ting those with elevated TPOAb levels but otherwise
euthyroid (normal thyroid hormone [ie fT3 and fT4]
levels) may rescue pregnancies destined for miscarriage.
Negro et al. reported a randomised trial suggesting ad-
ministering levothyroxine (a synthetic form of the thy-
roid hormone T4 that can be taken orally) to women
who are TPOAb positive may decrease the risk of mis-
carriage [5]. The results were quite remarkable, where
the risk of miscarriage with TPOab positivity and no
treatment was 13.8%, but decreased to only 3.5% with
treatment. However, the total cohort in that trial was
110 meaning this finding requires confirmation.
Given the exciting possibility that treating women
who are TPOAb positive may prevent cases of sporadic
miscarriage (a pregnancy complication that thus far has
remained remarkably resistant to any proposed treat-
ments), it may be timely to consider when may be the
most clinically pragmatic time to measure TPOAb levels.
For example, universal screening of all women of child-
bearing age, even those who have never been pregnant,
may not necessarily be the most appropriate strategy.
Universal screening will detect many who are TPOAb
positive but were never destined to suffer a pregnancy
loss as a result. Thus, it is perhaps not acceptable -
or cost effective - to universally screen, where poten-
tially 6% of the entire population [6,7] will be offered
treatment.
We propose the appropriate cohort to screen for
TPOAb levels may be nulliparous women presenting for
management for a miscarriage, for the following reasons:
1) it is clinically convenient as results could be reviewed
at the routine 6 week post-procedure check-up (hence
management may be streamlined) 2) measuring TPOAb
levels among women who have one or more miscar-
riages but never had a successful liveborn may enrichthe number of positive cases, compared to universal
screening 3) it may be more clinically acceptable (and
more cost effective) to treat women who are TPOAb
positive and have ever only miscarried, compared to
universal screening.
Therefore in this study, we measured TPOAb levels in
women nulliparous women presenting for surgical ma-
nagement of their missed miscarriage to: 1) independently
verify that TPOAb levels are elevated in association with
miscarriage and 2) verify TPOAb levels are not affected by
serum hCG and can therefore be validly assessed from a
sample obtained during this time.
Serum 25OH-Vitamin D (Vitamin D) deficiency du-
ring pregnancy has been linked to a number of adverse
maternal and fetal outcomes [8]. Whether vitamin D
deficiency increases risk of miscarriage has not been in-
vestigated. A link is plausible given that vitamin D defi-
ciency has been linked to increased autoimmunity [9],
including thyroid autoimmunity [10,11]. Moreover, the
immune system is known to play a critical role in
healthy placental implantation [12]. Therefore, we also




We conducted a prospective descriptive cohort study
at The Mercy Hospital for Women, a tertiary referral
centre in Victoria, Australia. Cases were women aged 18
years or older presenting for suction curette as treat-
ment for an incomplete miscarriage diagnosed by ultra-
sound during the first trimester. Controls were women
presenting at their first prenatal visit. We only inclu-
ded controls where the index pregnancy subsequently
progressed to a liveborn at term (>37 weeks gestation).
Therefore, the control population was defined as women
who never miscarried and had at least two successful
pregnancies (including the index pregnancy).
The study protocol was approved by the Human Re-
search Ethics Committee at Mercy Hospital for Women
and each subject provided written informed consent
prior to participation in the study.
Blood collection and analyses
9 mls of blood was drawn at presentation for curette
(cases) and during the first antenatal visit in the first tri-
mester of pregnancy for controls. Thus, cases and con-
trols were matched to the estimated gestation on day of
sample collection, where gestation was determined by
menstrual dates in miscarriage group and by either men-
strual dates and/or ultrasound dating in the control
group. Blood was spun at 3000 rpm for 15 minutes
at −4°C and the serum was collected and stored at −80°C
until assay.
Table 1 Baseline characteristics
Parameter Controls n = 162 Cases n = 118 P
Age (years) 31 33 0.028
(29 – 34) (28–37)
Ethnicity ns
Caucasian 85% 83%
West South Asian 12% 13%
North East Asian 1% 2%
Pacific 1% 2%
Gravidity 2 2 0.023
2–2.75 1 - 3
Parity* 2 0 < 0.0001









Birthweight (g) 3445 N/A -
3120 - 3780
Values in column 2 and 3 show median and interquartile range (25th to 75th
percentile) for each parameter, except ethnicity which is shown in %.
Wilcoxon rank sum test, P > 0.05 is considered non significant (ns).
* Parity includes the index pregnancy.
Table 2 Analyte values
Parameter Controls n = 162 Cases n = 118 P
TPOAb (IU/ml) 0.2 (0–0.5) 0.3 (0.2 - 0.7) < 0.0001
hCG (IU/L) 107,669 (85,431-139,738) 7,480 (1,627-24,896) < 0.0001
TSH (mIU/L) 0.66 (0.37 - 1.1) 0.98 (0.73 - 1.44) < 0.0001
fT4 (pmol/L) 14 (13 – 15) 13.9 (13 – 15) ns
fT3 (pmol/L) 4.3 (4.0 – 4.7) 3.9 (3.7 - 4.3) < 0.0001
Vitamin D
(nmol/L)
45 (30 – 62) 54 (40 – 65) 0.013
Analyte values are median and interquartile range (25th to 75th percentile).
Wilcoxon rank sum test used for all comparisons.
ns = non significant, where P > 0.05.
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using a chemiluminescent microparticle immunoassay
according to manufacturer’s instructions: TSH, free T4
(fT4), free T3 (fT3) and thyroid peroxidase antibodies
(TPOAb) (Architect Anti-TPO assay, Abbot Laboratories,
IL, USA). The assay used to quantify thyroid antibody
levels has an assay precision of <10% total coefficient of
variation. Given different cut-offs (from 5.61 to 12 IU/mL)
have been proposed to define to define TPOAb positivity
with this particular assay [1,13], we chose a priori not to
rely on any of these arbitrary cut-offs for our primary ana-
lysis but instead, report autoantibody levels as a quantita-
tive parameter.
hCG levels were measured using the Elegance hCG
ELISA kit (Bioclone, Australia), with an assay precision
of <10% total coefficient of variation (for hCG levels of
4.5 IU/L).
Serum 25OH-Vitamin D (Vitamin D) was measured
using the Liaison25OH vitamin D TOTAL (DiaSorin
Inc., Stillwater, MN, USA), a direct competitive chemilu-
minescent immunoassay with an interassay coefficient of
variation of 7.0% at 45 nmol/L and 6.3% at 93 nmol/L.
Data analysis
We used descriptive statistics to report clinical base-
line characteristics and analyte values, where quantitative
values were expressed as the median and interquartile
range (25th - 75th percentiles). Differences between the
miscarriage and the control group were analysed by
means of nonparametric Wilcoxon rank sum test or
chi-square test. Correlations analysis of analytes was
performed using spearman’s rank correlation.
Results
We recruited 118 cases of women presenting for surgical
management for a missed miscarriage, diagnosed by
ultrasound. From a prospective biobank collection of
1051 samples that were collected at the same hospital
contemporaneously, we selected 164 controls, defined as
women who never miscarried, had had at least one pre-
vious liveborn, and would also go on and successfully
deliver a term pregnancy in the index pregnancy (ie at
least 2 liveborn and no miscarriage). Serum samples
were collected on the day of surgical management for
the miscarriage group, and during the mid-first trimester
for the control group.
Table 1 shows the baseline characteristics of the 118
cases with miscarriage and the 162 controls with suc-
cessful term delivery. Of the 118 cases of miscarriage,
69% (n = 81) had had one miscarriage, 22% (n = 26) had
two, 6% (n = 7) had three, and 3% (n = 4) had suffered
four or more miscarriages. Cases were older (p = 0.028),
and there were no differences in ethnicity. The median
gestational age at sampling in the missed miscarriagegroup was 9 weeks’ gestation (ie 9 weeks after their last
menstrual period), although fetal demise would have oc-
curred at a variable time prior. However, the data on
date of sampling relative to the last menstrual period is
relevant as it suggests all those recruited had suffered
first trimester miscarriages. Thus, the gestation at sam-
ple collection is similar to that for the control group.
Those in the control group all delivered at term with
normal birthweights (Table 1).
When examined quantitatively, TPOAb levels were
significantly higher in the miscarriage cohort compared
to controls (p < 0.0001; Table 2). TPOAb in miscarriage
group was 0.3 mIU/L (interquartile range [IR]: 0.2-0.7)
vs 0.2 mIU/L among controls (IR 0.0-0.5; P < 0.0001).
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IU/mL (suggested by the manufacturer as this value
is >2 standard deviations from the population mean),
the incidence of TPOAb positivity in the control popula-
tion was 14.4% in the miscarriage cohort, compared to
8.8% in the control group, a difference that was not sta-
tistically significant (P = 0.18). It is possible this differ-
ence may be significant if our study had more numbers
given differences in TPOAb titres were highly significant
when assessed as a quantitative variable.
At the time of presentation, human chorionic gonado-
trophin is likely to be present in the serum, though ac-
tively declining. Thus, to validly screen TPOAb titres at
the time women present for management of their mis-
carriage, it would be important to verify levels are not
influenced by serum hCG concentrations. Therefore, we
performed correlations between TPOAb and hCG in
both the miscarriage and control cohorts where the
median hCG levels were 7,480 IU/L and 107,669 IU/L
respectively. In both statistical comparisons there was
no correlation (r values 0.05 cases and −0.01 controls,
P ≥ 0.54) between the two analytes suggesting TPOAb
are not affected by serum hCG levels (Table 3).
TSH and fT3 levels were significantly higher in the
miscarriage cohort compared to controls (Table 2). We
also performed correlations between TSH, fT3 and fT4
with serum hCG among cases and controls (Table 3). In
contrast to TPOAb, there were some analytes that were
either significantly correlated with serum hCG (TSH
among the control cohort, r = −0.25, P = 0.0021), or tren-
ded towards a correlation that just failed to meet sig-
nificance (fT3 among the miscarriage cohort, r = 0.16,
p = 0.085; or fT4 among controls, r = 0.14, P = 0.087; see
Table 3).
Of the entire cohort, only 12% were vitamin D suffi-
cient (defined as vitamin D >75 nmol/L). 37% had vita-
min D insufficiency (50–75 nmol/L), 40% mild (25–49
nmol/L) and 11% severe (<25 nmol/L) vitamin D defi-
ciency. Contrary to our hypothesis, absolute vitamin D
levels were in fact higher overall in the women who mis-
carried compared to women with successful term deli-
very (P = 0.013; Table 2).Table 3 Analyte correlations with serum hCG
Parameter Controls Cases
r = p r = p
TPOAb (IU/ml) −0.01 0.87 0.05 0.54
TSH (mIU/L) −0.25 0.0021 −0.06 0.47
fT4 (pmol/L) 0.14 0.087 0.12 0.21
fT3 (pmol/L) −0.13 0.12 0.16 0.085
All analytes were correlated with serum hCG using spearman’s
rank correlation.Discussion
While half of all miscarriages are associated with chro-
mosomal abnormalities, the remainder are euploid where
miscarriage probably occurs as a result of implantation
failure [14]. Thus, a significant proportion of these euploid
miscarriages are potentially salvageable [15].
The possibility levothyroxine may salvage some mis-
carriages caused by TPOAb is a potentially important
finding given approximately 6% of women in early preg-
nancy may be TPOAb positive [6,7]. It is perhaps now
timely to consider how such a test could be meaningfully
integrated into clinical care. This might inform both fu-
ture clinical practice and the design of validation trials
of levothyroxine treatment for miscarriage in women
who are TPOAb positive.
We would propose women who have never previously
had a liveborn but have suffered one or more mis-
carriages may be the appropriate cohort to screen for
TPOAb. And we suggest it would be clinically pragmatic
to screen women on the day women they present for
management of their miscarriage. The TPOAb results
can be reviewed at a six-week review where potentially,
levothyroxine could be prescribed. The approach is analo-
gous to current clinical management of unexplained still-
births, where a number of tests are performed during
the time women are admitted for induction of labour to
empty the uterus.
In this study, we have independently confirmed that
higher levels of TPOAb are associated with miscarriage
[1-4]. Furthermore, we have confirmed TPOAb levels do
not significantly vary with serum hCGs levels suggesting
it is may be valid to screen for TPOAb at the time
women present for management of their miscarriage.
This contrasts with our results for TSH, fT3 and fT4,
where we observed correlations with serum hCG levels
that were either significant, or just failed to meet signifi-
cance. This suggests while hCG is able to stimulate the
TSH receptor, it does not appear to affect TPOAb levels.
Among the control group, the prevalence of TPOAb
was 8.8% (when using the manufacturer’s cut off defined
as > 2 standard deviations above the mean). This figure
is relatively similar to the prevalence of TPOAb positiv-
ity reported in two very large cohort studies. Abbassi-
Ghanavati et al. measured TPOAb in serum samples
from 17,298 women within the first 20 weeks of gesta-
tion and found 6% were TPOAb positive [6]. Similarly,
Clearly-Goldman et al. also reported the prevalence of
TPOAb positivity among 10,990 samples obtained in the
first trimester was 6% [7]. This suggests potentially, our
findings may be generalisable to other populations.
Vitamin D deficiency was not associated with an in-
creased risk of miscarriage in our study. In fact, we
found vitamin D levels were increased among those who
miscarried. This finding was contrary to our hypothesis,
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min D deficiency is associated with thyroid autoimmu-
nity [10,11], as well as other autoimmune diseases in
which miscarriage rates may be increased [9]. The bio-
logical significance of this finding, if any, is unclear.
Given this ran contrary to our hypothesis and the P
value just reached significance (P = 0.013), this finding
may be a Type I error. Therefore, it firstly requires con-
firmation in future studies before it merits further
consideration.
It is remarkable that even in a region with relatively
high levels of sunlight such as southeast Australia, only
12% of pregnant women of predominantly Caucasian
descent are vitamin D sufficient. The high prevalence of
insufficient vitamin D levels in our cohort is potentially
concerning, given that maternal vitamin D deficiency
may be associated with a number of adverse pregnancy
outcomes [8]. However, the optimal vitamin D level to
reduce the risk of pregnancy-associated complications
remains unknown.
Our study has some strengths. All samples were col-
lected prospectively and processed in a similar manner
at a single centre. The laboratory analyses’ were done in
one batch, and by an operator blinded to the sample
identities. Finally, we used commercial assays that are
used to process samples for clinical care.Conclusions
We have shown TPOAb levels are increased in asso-
ciation with miscarriage, compared to women who
have had 2 or more livebirths and never miscarried.
We also shown TPOAb levels are independent of se-
rum hCG levels and could be screened clinically at
the time women present for management of an in-
complete miscarriage.
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